Blood Filtration and Purification Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample preparation systems, Specialty assays and columns), By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others), By End-User

The Blood Filtration and Purification Market is valued at USD 3.69 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 7.02 billion by 2034. Blood Filtration and Purification M... もっと見る

出版社	出版年月	電子版価格	納期	言語
OG Analysis オージーアナリシス	2025年11月11日	US$3,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	通常3-4営業日以内	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

Table of Contents

Summary

The Blood Filtration and Purification Market is valued at USD 3.69 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 7.02 billion by 2034.

Blood Filtration and Purification Market

The blood filtration and purification market encompasses extracorporeal therapies and transfusion-focused filtration products that remove toxins, excess solutes, immune mediators, pathogens, and cellular contaminants. Core modalities include renal replacement (hemodialysis, hemofiltration, hemodiafiltration, CRRT), selective apheresis (plasma exchange, immunoadsorption, LDL apheresis), hemoperfusion and cytokine/endotoxin adsorption, and transfusion filters for leukoreduction, microaggregate removal, and pathogen-reduction of blood components. End-uses span chronic kidney disease and acute kidney injury in ICUs; sepsis and inflammatory syndromes; liver failure; autoimmune and hematological disorders; cardiac surgery and ECMO adjunct support; oncology-related cytokine storms; and blood banking/ transfusion safety. Trends emphasize cartridge innovations with higher adsorptive capacity and biocompatible surfaces, integrated CRRT platforms with precision dosing and citrate anticoagulation workflows, and expanding pathogen-reduction technologies in blood centers. Digitalization is advancing with sensor-equipped circuits, closed-loop fluid management, and interoperable data for dose tracking and outcomes documentation. Growth drivers include aging populations, rising ICU admissions, greater awareness of extracorporeal organ support, and stricter transfusion standards. The competitive landscape blends diversified renal companies, apheresis specialists, sorbent and membrane innovators, and blood-bank technology providers, with differentiation in clinical evidence, device ease-of-use, disposable cost, and service reach. Key challenges are variable evidence strength for certain hemoperfusion indications, anticoagulation management and bleeding risk, staffing/training requirements, reimbursement variability across regions, and supply chain resilience for polymers, resins, and sterile disposables. Suppliers pairing robust clinical programs with turnkey training, reliable logistics, and outcome-linked value propositions are best positioned.

Blood Filtration and Purification Market Key Insights

• CRRT is the ICU workhorse Integrated pumps, precise fluid balancing, and citrate anticoagulation make CRRT the default for hemodynamically unstable AKI. Modalities are increasingly personalized by solute targets, catabolic rate, and fluid tolerance.
• Hemoadsorption broadens beyond sepsis Porous polymer and resin cartridges target cytokines, endotoxin, bilirubin, and myoglobin. Adoption correlates with protocols that define timing, patient selection, and endpoints to complement standard of care.
• Selective apheresis grows in immune and lipid disorders Immunoadsorption columns and LDL apheresis offer disease-modifying options where drugs are inadequate or contraindicated. Success hinges on center expertise, access to trained staff, and predictable consumable supply.
• Pathogen reduction strengthens blood safety Photochemical and riboflavin-based systems reduce bacterial and viral risk in platelets and plasma. Blood centers weigh shelf-life and logistics benefits against cost and workflow changes.
• Leukoreduction is standardizing globally Pre-storage and bedside filters mitigate febrile reactions, CMV transmission, and alloimmunization. Hospitals favor universal policies where supply and cost allow, simplifying inventory and improving outcomes.
• Membrane and sorbent materials matter High-flux and medium cut-off membranes enhance middle-molecule clearance; coated fibers reduce complement activation. Sorbent chemistry defines selectivity, pressure stability, and saturation kinetics.
• Anticoagulation and safety are program limiters Citrate protocols reduce bleeding but require calcium management and staff competency. Device-embedded guidance, alarms, and point-of-care analytics reduce variability and sentinel events.
• Evidence and economics drive formulary access Hospitals seek clear data on LOS, vasopressor use, dialysis dependence, or transfusion reactions prevented. Bundled pricing, rental consoles, and per-treatment economics support adoption.
• Interoperability and data capture win tenders Connectivity to EMR/ICU systems, dose calculators, and automated documentation ease audits and quality reporting. Remote troubleshooting and usage analytics improve uptime.
• Sustainability enters specifications Light-protected bag systems, recyclable components, and reduced priming volumes lower waste and cost. Vendors offering re-engineered packaging and route-optimized logistics gain scoring advantages.

Blood Filtration and Purification Market Reginal Analysis

North America

High ICU capacity and established renal networks drive consistent CRRT usage with advanced anticoagulation workflows. Interest in hemoadsorption rises in select centers under protocolized pathways. Blood banks push leukoreduction and adopt targeted pathogen-reduction; reimbursement and value analysis committees require outcome documentation and service guarantees.

Europe

Guideline-driven procurement emphasizes evidence strength, biocompatibility, and data interoperability. Universal leukoreduction is common; pathogen-reduction adoption varies by country policy. CRRT platforms compete on ease-of-use and citrate support; hemoperfusion expands in specialized centers with registry participation and strict governance.

Asia-Pacific

Rapid ICU investment and growing dialysis burden expand demand across CRRT and blood safety technologies. Large markets balance premium platforms with value-tier disposables; training and distributor service are decisive. Japan and Australia lead in protocolized extracorporeal therapies; emerging economies scale leukoreduction and improve transfusion quality.

Middle East & Africa

Tertiary hospitals and government hubs procure turnkey CRRT fleets with comprehensive training. Select sites adopt hemoadsorption for surgical and septic shock cases; blood centers prioritize leukoreduction as supply stabilizes. Harsh-climate logistics, Arabic/French IFUs, and vendor on-site support influence awards.

South & Central America

Urban referral centers expand CRRT and apheresis capabilities; budget variability favors rental consoles and per-diem consumable models. Blood services advance leukoreduction policies and upgrade screening/filtration infrastructure. Local technical service, predictable disposables supply, and bilingual education materials are critical for continuity.

Blood Filtration and Purification Market Segmentation

By Product

Filtration Kits and Reagents

Membranes

Filters and Consumables

Sample preparation systems

Specialty assays and columns

By Application

Infectious Disease Diagnostics

Toxicology and Immunodiagnostics

Cancer Diagnostics

Genetic/Molecular Diagnostics

Others

By End-User

Clinical Diagnostic Labs

Hospitals

Research and Academic Institutes

Others

Key Market players

Fresenius Medical Care, Baxter International, B. Braun Melsungen, Nipro Corporation, Asahi Kasei Corporation, Jafron Biomedical, Pandora’s [correction: need “ExThera Medical”], ExThera Medical, Aethlon Medical, NxStage Medical, Haemonetics Corporation, Thermo Fisher Scientific, Pall Corporation, Cerus Corporation, Toray Medical Co Ltd

Blood Filtration and Purification Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends. Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Blood Filtration and Purification Market Competitive Intelligence

The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption. Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

North America — Blood Filtration and Purification market data and outlook to 2034
- United States
- Canada
- Mexico
Europe — Blood Filtration and Purification market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- BeNeLux
- Russia
- Sweden
Asia-Pacific — Blood Filtration and Purification market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
Middle East and Africa — Blood Filtration and Purification market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
South and Central America — Blood Filtration and Purification market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru

* We can include data and analysis of additional countries on demand.

Research Methodology

This study combines primary inputs from industry experts across the Blood Filtration and Purification value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

What is the current and forecast market size of the Blood Filtration and Purification industry at global, regional, and country levels?

Which types, applications, and technologies present the highest growth potential?

How are supply chains adapting to geopolitical and economic shocks?

What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?

Who are the leading players, and how are their strategies evolving in the face of global uncertainty?

Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?

Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

Your Key Takeaways from the Blood Filtration and Purification Market Report

Global Blood Filtration and Purification market size and growth projections (CAGR), 2024-2034
Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Blood Filtration and Purification trade, costs, and supply chains
Blood Filtration and Purification market size, share, and outlook across 5 regions and 27 countries, 2023-2034
Blood Filtration and Purification market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
Short- and long-term Blood Filtration and Purification market trends, drivers, restraints, and opportunities
Porter’s Five Forces analysis, technological developments, and Blood Filtration and Purification supply chain analysis
Blood Filtration and Purification trade analysis, Blood Filtration and Purification market price analysis, and Blood Filtration and Purification supply/demand dynamics
Profiles of 5 leading companies—overview, key strategies, financials, and products
Latest Blood Filtration and Purification market news and developments

Additional Support

With the purchase of this report, you will receive

An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
Complimentary report update to incorporate the latest available data and the impact of recent market developments.

* The updated report will be delivered within 3 working days"

ページTOPに戻る

1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Global Blood Filtration and Purification Market Summary, 2025
2.1 Blood Filtration and Purification Industry Overview
2.1.1 Global Blood Filtration and Purification Market Revenues (In US$ billion)
2.2 Blood Filtration and Purification Market Scope
2.3 Research Methodology

3. Blood Filtration and Purification Market Insights, 2024-2034
3.1 Blood Filtration and Purification Market Drivers
3.2 Blood Filtration and Purification Market Restraints
3.3 Blood Filtration and Purification Market Opportunities
3.4 Blood Filtration and Purification Market Challenges
3.5 Tariff Impact on Global Blood Filtration and Purification Supply Chain Patterns

4. Blood Filtration and Purification Market Analytics
4.1 Blood Filtration and Purification Market Size and Share, Key Products, 2025 Vs 2034
4.2 Blood Filtration and Purification Market Size and Share, Dominant Applications, 2025 Vs 2034
4.3 Blood Filtration and Purification Market Size and Share, Leading End Uses, 2025 Vs 2034
4.4 Blood Filtration and Purification Market Size and Share, High Growth Countries, 2025 Vs 2034
4.5 Five Forces Analysis for Global Blood Filtration and Purification Market
4.5.1 Blood Filtration and Purification Industry Attractiveness Index, 2025
4.5.2 Blood Filtration and Purification Supplier Intelligence
4.5.3 Blood Filtration and Purification Buyer Intelligence
4.5.4 Blood Filtration and Purification Competition Intelligence
4.5.5 Blood Filtration and Purification Product Alternatives and Substitutes Intelligence
4.5.6 Blood Filtration and Purification Market Entry Intelligence

5. Global Blood Filtration and Purification Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
5.1 World Blood Filtration and Purification Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
5.1 Global Blood Filtration and Purification Sales Outlook and CAGR Growth By Product, 2024- 2034 ($ billion)
5.2 Global Blood Filtration and Purification Sales Outlook and CAGR Growth By Application, 2024- 2034 ($ billion)
5.3 Global Blood Filtration and Purification Sales Outlook and CAGR Growth By End-User, 2024- 2034 ($ billion)
5.4 Global Blood Filtration and Purification Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

6. Asia Pacific Blood Filtration and Purification Industry Statistics – Market Size, Share, Competition and Outlook
6.1 Asia Pacific Blood Filtration and Purification Market Insights, 2025
6.2 Asia Pacific Blood Filtration and Purification Market Revenue Forecast By Product, 2024- 2034 (USD billion)
6.3 Asia Pacific Blood Filtration and Purification Market Revenue Forecast By Application, 2024- 2034 (USD billion)
6.4 Asia Pacific Blood Filtration and Purification Market Revenue Forecast By End-User, 2024- 2034 (USD billion)
6.5 Asia Pacific Blood Filtration and Purification Market Revenue Forecast by Country, 2024- 2034 (USD billion)
6.5.1 China Blood Filtration and Purification Market Size, Opportunities, Growth 2024- 2034
6.5.2 India Blood Filtration and Purification Market Size, Opportunities, Growth 2024- 2034
6.5.3 Japan Blood Filtration and Purification Market Size, Opportunities, Growth 2024- 2034
6.5.4 Australia Blood Filtration and Purification Market Size, Opportunities, Growth 2024- 2034

7. Europe Blood Filtration and Purification Market Data, Penetration, and Business Prospects to 2034
7.1 Europe Blood Filtration and Purification Market Key Findings, 2025
7.2 Europe Blood Filtration and Purification Market Size and Percentage Breakdown By Product, 2024- 2034 (USD billion)
7.3 Europe Blood Filtration and Purification Market Size and Percentage Breakdown By Application, 2024- 2034 (USD billion)
7.4 Europe Blood Filtration and Purification Market Size and Percentage Breakdown By End-User, 2024- 2034 (USD billion)
7.5 Europe Blood Filtration and Purification Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
7.5.1 Germany Blood Filtration and Purification Market Size, Trends, Growth Outlook to 2034
7.5.2 United Kingdom Blood Filtration and Purification Market Size, Trends, Growth Outlook to 2034
7.5.2 France Blood Filtration and Purification Market Size, Trends, Growth Outlook to 2034
7.5.2 Italy Blood Filtration and Purification Market Size, Trends, Growth Outlook to 2034
7.5.2 Spain Blood Filtration and Purification Market Size, Trends, Growth Outlook to 2034

8. North America Blood Filtration and Purification Market Size, Growth Trends, and Future Prospects to 2034
8.1 North America Snapshot, 2025
8.2 North America Blood Filtration and Purification Market Analysis and Outlook By Product, 2024- 2034 ($ billion)
8.3 North America Blood Filtration and Purification Market Analysis and Outlook By Application, 2024- 2034 ($ billion)
8.4 North America Blood Filtration and Purification Market Analysis and Outlook By End-User, 2024- 2034 ($ billion)
8.5 North America Blood Filtration and Purification Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
8.5.1 United States Blood Filtration and Purification Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Canada Blood Filtration and Purification Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Mexico Blood Filtration and Purification Market Size, Share, Growth Trends and Forecast, 2024- 2034

9. South and Central America Blood Filtration and Purification Market Drivers, Challenges, and Future Prospects
9.1 Latin America Blood Filtration and Purification Market Data, 2025
9.2 Latin America Blood Filtration and Purification Market Future By Product, 2024- 2034 ($ billion)
9.3 Latin America Blood Filtration and Purification Market Future By Application, 2024- 2034 ($ billion)
9.4 Latin America Blood Filtration and Purification Market Future By End-User, 2024- 2034 ($ billion)
9.5 Latin America Blood Filtration and Purification Market Future by Country, 2024- 2034 ($ billion)
9.5.1 Brazil Blood Filtration and Purification Market Size, Share and Opportunities to 2034
9.5.2 Argentina Blood Filtration and Purification Market Size, Share and Opportunities to 2034

10. Middle East Africa Blood Filtration and Purification Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2025
10.2 Middle East Africa Blood Filtration and Purification Market Statistics By Product, 2024- 2034 (USD billion)
10.3 Middle East Africa Blood Filtration and Purification Market Statistics By Application, 2024- 2034 (USD billion)
10.4 Middle East Africa Blood Filtration and Purification Market Statistics By End-User, 2024- 2034 (USD billion)
10.5 Middle East Africa Blood Filtration and Purification Market Statistics by Country, 2024- 2034 (USD billion)
10.5.1 Middle East Blood Filtration and Purification Market Value, Trends, Growth Forecasts to 2034
10.5.2 Africa Blood Filtration and Purification Market Value, Trends, Growth Forecasts to 2034

11. Blood Filtration and Purification Market Structure and Competitive Landscape
11.1 Key Companies in Blood Filtration and Purification Industry
11.2 Blood Filtration and Purification Business Overview
11.3 Blood Filtration and Purification Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis

12 Appendix
12.1 Global Blood Filtration and Purification Market Volume (Tons)
12.1 Global Blood Filtration and Purification Trade and Price Analysis
12.2 Blood Filtration and Purification Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Blood Filtration and Purification Industry Report Sources and Methodology

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

OG Analysis社のヘルスケア・医薬品分野での最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート

よくあるご質問

OG Analysis社はどのような調査会社ですか?

OG Analysisは、10年以上の専門知識を持ち、半導体、エネルギー、化学品、自動車、農業など多様な市場調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行っています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。